Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors.

Rani Khatib Mutiba KhanAbigail BarrowcliffEunice IkongoClaire BurtonMichael MansfieldAlistair Hall

Published in: Open heart (2022)

This innovative, person-centred, multidisciplinary service successfully initiated PCSK9i therapy for eligible patients and drove long-term monitoring, adherence and cholesterol lowering. It also provided medicines optimisation and adherence assistance to PCSK9i-ineligible patients. The model could be used in other areas to support better uptake and optimisation of PCSK9i therapy.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
low density lipoprotein
healthcare
prognostic factors
peritoneal dialysis
stem cells
primary care
type diabetes
mental health
mesenchymal stem cells
insulin resistance
glycemic control
patient reported